Heart2Action: Dr Lim Wei Juan Highlights Evidence-Based Strategies for Early LDL-C Reduction
Early LDL-C reduction is an important component of cardiovascular disease prevention. On 10 October 2026, Dr Lim Wei Juan, Consultant in Internal Medicine and Cardiology at Johor Specialist Hospital, was featured as the speaker at Heart2Action: Evidence Driven Strategies for Early LDL-C Reduction, an educational event held at Sheraton Johor Bahru, Johor, Malaysia.
Presented with Organon featured on the event programme, the session focused on a key priority in modern cardiovascular care: translating clinical evidence into practical strategies for managing low-density lipoprotein cholesterol (LDL-C) and reducing cardiovascular risk.
Understanding the Importance of Early LDL Cholesterol Reduction
LDL cholesterol is commonly known as “bad cholesterol” because elevated levels contribute to the development and progression of atherosclerotic cardiovascular disease (ASCVD). Over time, cholesterol can accumulate within artery walls, contributing to plaque formation, narrowing of the arteries and an increased risk of serious cardiovascular events.
For individuals at increased cardiovascular risk, effective cholesterol management is an essential part of long-term prevention. Identifying elevated LDL-C, assessing the patient’s overall cardiovascular risk and initiating appropriate treatment in a timely manner can help improve lipid control and support better cardiovascular health.
Current European Society of Cardiology and European Atherosclerosis Society guidance reinforces the importance of individualised risk assessment and appropriate intensification of LDL-C-lowering treatment, particularly in high-risk patients. Treatment decisions should be guided by the patient’s clinical circumstances, treatment goals and response to therapy.
From Clinical Evidence to Everyday Cardiovascular Practice
The Heart2Action programme highlighted the importance of evidence-driven approaches to early LDL-C reduction. In clinical practice, effective lipid management requires more than simply identifying a high cholesterol result.
A comprehensive approach includes:
- Individual cardiovascular risk assessment: Considering the patient’s medical history, existing cardiovascular disease and other relevant risk factors.
- Appropriate LDL-C treatment goals: Setting treatment objectives according to the patient’s overall level of cardiovascular risk.
- Timely initiation and optimisation of therapy: Selecting suitable cholesterol-lowering treatment and reviewing whether the desired response has been achieved.
- Ongoing monitoring and follow-up: Assessing lipid levels, treatment response, adherence and tolerability, with adjustments when clinically appropriate.
Evidence-based lipid management helps clinicians make informed decisions while keeping treatment individualised to each patient’s needs.
Advancing Cardiovascular Education in Johor Bahru
The Heart2Action event took place on Saturday, 10 October 2026, at Sheraton Johor Bahru, from 6:30 PM to 9:00 PM.
The programme included registration, welcoming remarks, an e-referral introduction, a health talk by Dr Lim Wei Juan and a dinner and networking session. The gathering provided a setting for professional education and networking around contemporary approaches to cholesterol management and cardiovascular risk reduction.
Continuing medical education plays an important role in helping healthcare professionals stay informed about evolving clinical evidence and incorporate appropriate strategies into patient care.
Dr Lim Wei Juan – Consultant Cardiologist at Johor Specialist Hospital
Dr Lim Wei Juan is a Consultant Cardiologist at Johor Specialist Hospital in Johor Bahru, Malaysia. With previous cardiology training at the National Heart Institute (Institut Jantung Negara, IJN), his clinical interests include coronary artery disease, interventional cardiology and the management of patients with cardiovascular conditions.
His areas of interest include coronary angiography, percutaneous coronary intervention (PCI) and advanced coronary interventions, alongside the assessment and management of cardiovascular risk factors.
Through clinical practice and professional education, Dr Lim aims to support evidence-based cardiovascular care and help patients better understand the importance of prevention, early assessment and appropriate treatment.
Taking Action for Better Heart Health
Managing LDL cholesterol early, when clinically indicated, is an important step towards reducing the long-term burden of cardiovascular disease. Regular medical assessment, appropriate cholesterol testing, lifestyle measures and individualised treatment can help patients and healthcare professionals work together towards better cardiovascular health.
Through initiatives such as Heart2Action, the focus remains on connecting clinical evidence with everyday medical practice and strengthening awareness of effective cardiovascular risk management.
For patients in Johor Bahru seeking assessment of cholesterol levels, cardiovascular risk or heart-related conditions, Johor Specialist Hospital provides cardiology consultation and diagnostic services to support individualised care.
Take a proactive approach to your heart health. Discuss your cholesterol levels and cardiovascular risk with a qualified healthcare professional to understand the most appropriate prevention and treatment options for you.